These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

960 related items for PubMed ID: 12072383

  • 1. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT, Mosekilde L, Mitova-Caneva NG, Thomsen JS, Wronski TJ.
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [Abstract] [Full Text] [Related]

  • 2. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L.
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [Abstract] [Full Text] [Related]

  • 3. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE, Yao W, Kinney JH, Modin G, Balooch M, Wronski TJ.
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M, Mosekilde L, Søgaard CH, Thomsen JS, Wronski TJ.
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [Abstract] [Full Text] [Related]

  • 5. Bone anabolic effects of subcutaneous treatment with basic fibroblast growth factor alone and in combination with estrogen in osteopenic ovariectomized rats.
    Iwaniec UT, Magee KA, Mitova-Caneva NG, Wronski TJ.
    Bone; 2003 Sep; 33(3):380-6. PubMed ID: 13678780
    [Abstract] [Full Text] [Related]

  • 6. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
    Yao W, Balooch G, Balooch M, Jiang Y, Nalla RK, Kinney J, Wronski TJ, Lane NE.
    Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
    [Abstract] [Full Text] [Related]

  • 7. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
    Iwaniec UT, Moore K, Rivera MF, Myers SE, Vanegas SM, Wronski TJ.
    Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ, Yen CF, Qi H, Dann LM.
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats.
    Wang L, Orhii PB, Banu J, Kalu DN.
    Bone; 2001 Feb; 28(2):202-7. PubMed ID: 11182379
    [Abstract] [Full Text] [Related]

  • 13. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model.
    Mosekilde L, Danielsen CC, Søgaard CH, McOsker JE, Wronski TJ.
    Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051
    [Abstract] [Full Text] [Related]

  • 14. PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats.
    Mosekilde L, Søgaard CH, McOsker JE, Wronski TJ.
    Bone; 1994 Feb; 15(4):401-8. PubMed ID: 7917578
    [Abstract] [Full Text] [Related]

  • 15. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD, Wronski TJ.
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA.
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [Abstract] [Full Text] [Related]

  • 17. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE.
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [Abstract] [Full Text] [Related]

  • 18. The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates.
    Søgaard CH, Wronski TJ, McOsker JE, Mosekilde L.
    Endocrinology; 1994 Feb; 134(2):650-7. PubMed ID: 8299562
    [Abstract] [Full Text] [Related]

  • 19. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT, Samnegård E, Cullen DM, Kimmel DB.
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [Abstract] [Full Text] [Related]

  • 20. Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model.
    Lane NE, Kumer J, Yao W, Breunig T, Wronski T, Modin G, Kinney JH.
    Osteoporos Int; 2003 Jun; 14(5):374-82. PubMed ID: 12768279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.